Just to let you know that the Freedom of Information request to all Strategic Health Authorities (SHAs) is now live. The questions we have asked are listed below, I’ll keep you up-to-date with progress.

Best,

Kris

1) How many people within your catchment area have been diagnosed with Chronic Myeloid Leukaemia (CML) in:
a) 2008
b) 2009
c) 2010
d) 2011
e) 2012

2) Is Dasatinib (Sprycel) currently on your approved list of treatments that can be funded under the Cancer Drugs Fund (CDF)?
– If not, is there any particular reason for this and could it be easily added?

3) How many applications for funding for Dasatinib did you receive under the interim Cancer Drugs Fund, between 1st October 2010 and 31st March 2011?
– Of these applications, how many were successful?

4) How many applications for funding for Dasatinib did you receive in the first year of the full Cancer Drugs Fund from 1st April 2011 to 31st March 2012?
– Of these applications, how many were successful?

5) How many applications for Dasatinib have you received in the second year of the full Cancer Drugs Fund since 1st April 2012?
– Of these applications, how many were successful?